About Stimuplant
Stimuplant is an Agriculture company based in Mount Edgecombe (South Africa) founded in 1978. It offers bacteria inoculation and growth promoters for improved crop yield and plant health. It operates on a B2B and D2C model. The company has 132 employees. Its Indian entity Upl Limited reported revenue of ₹52,753 Cr. Stimuplant offers products and services including B-RUS, EXTRASOL, and Inoculant. Its focus areas include Food and Agriculture Tech, Crop Enhancement, Fertilization and Bacteria Inoculation.
Company details
Stimuplant, under UPL Ltd, specializes in bacteria inoculation for effective root nodulation in crops like soybeans, ensuring better nitrogen fixation and higher yields. It also provides growth promoters such as B-RUS and EXTRASOL to enhance root development, nutrient uptake, and disease resistance. These products are applied to seeds of various crops including maize and vegetables, helping farmers increase output naturally. Based in South Africa, it targets agricultural professionals for sustainable farming practices.
- Headquarters Mount Edgecombe, South Africa
- Employees 132
- SectorsAgriculture
- Email••••••••
- Website stimuplant.co.za
- Social LinkedIn
- Legal Name Upl Ltd
- Date of Incorporation 02 Jan, 1985
- Jurisdiction Valsad, Gujarat, India
- Indian entity revenue₹52,753 Cr
FY 2026 · +11% YoY
- Indian entity net profit₹1,785 Cr
FY 2026 · 3% margin
- Indian entity EBITDA₹8,888 Cr
FY 2026 · 17% margin
- Employee Count132
Associated legal entities of Stimuplant
Stimuplant operates through Upl Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Upl Limited Listed CIN L24219GJ1985PLC025132 | Active | 02 Jan 1985 | Valsad, Gujarat | ₹52,753 Cr | 4,125 | 11 | View details |
Products & Services of Stimuplant
Stimuplant offers a comprehensive portfolio of products and services, including B-RUS, EXTRASOL, and Inoculant.
Bacterial promoter enhancing root development and nutrient uptake for crops.
Natural microorganism for boosting plant immune system and yield naturally.
Treatment to minimize losses from Crown Gall in ornamental and crop plants.
Board of directors of Upl Limited (Stimuplant)
Upl Limited is the primary company behind Stimuplant. The board of Upl Limited currently have 9 directors; the longest-serving is Jaidev Rajnikant Shroff, appointed in 1992. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jaidev Rajnikant Shroff DIN 00191050 | Director | 01 Oct 1992 | 34 yrs 1 mo | Upl Limited |
| Vikram Rajnikant Shroff DIN 00191472 | Director | 22 Apr 2006 | 20 yrs 6 mo | Upl Limited |
| Hardeep Singh DIN 00088096 | Director | 02 Feb 2015 | 11 yrs 9 mo | Upl Limited |
| Naina Lal Kidwai DIN 00017806 | Director | 01 Oct 2021 | 5 yrs 1 mo | Upl Limited |
| Suresh Kumar DIN 00512630 | Director | 20 Oct 2022 | 4 yrs | Upl Limited |
| Raj Kumar Tiwari DIN 09772257 | Whole-time director | 01 Nov 2022 | 4 yrs | Upl Limited |
| Usha Rao Monari DIN 08652684 | Director | 18 Aug 2023 | 3 yrs 2 mo | Upl Limited |
| Bhanumathi Viswanathan Melattur DIN 10172983 | Director | 01 Feb 2025 | 1 yr 9 mo | Upl Limited |
| Santosh Kumar Mohanty DIN 06690879 | Director | 06 Mar 2025 | 1 yr 8 mo | Upl Limited |
Financials of Stimuplant
Figures of Upl Limited, the primary company behind Stimuplant, for FY 2026. Revenue was ₹52,753 Cr (+11% year on year). Net profit was ₹1,785 Cr (3% margin). EBITDA was ₹8,888 Cr (17% margin). Revenue has grown at a compounded annual rate of -1% over three years and +6% over five years.
- ₹52,753 CrRevenue · FY 2026 · +11% YoY
- ₹1,785 CrNet profit · 3% margin
- ₹8,888 CrEBITDA · 17% margin
- ₹169 CrPaid-up capital
- 4,125Employees (provident fund records)
- -1%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Upl Limited are on its company page.
Detailed financial statements for Stimuplant
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Stimuplant
Complete news archive for Stimuplant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stimuplant
Stimuplant was founded in 1978.
Stimuplant is headquartered in Mount Edgecombe, South Africa. It is registered at Mount Edgecombe, Kwazulu-natal, South Africa.
Stimuplant has 132 employees.
The primary company behind Stimuplant, Upl Limited, reported revenue of ₹52,753 Cr for FY 2026, up 11% year on year.
Stimuplant, under UPL Ltd, specializes in bacteria inoculation for effective root nodulation in crops like soybeans, ensuring better nitrogen fixation and higher yields. It also provides growth promoters such as B-RUS and EXTRASOL to enhance root development, nutrient uptake, and disease resistance. These products are applied to seeds of various crops including maize and vegetables, helping farmers increase output naturally. Based in South Africa, it targets agricultural professionals for sustainable farming practices.
Stimuplant offers B-RUS, EXTRASOL, and Inoculant.
Stimuplant operates through Upl Limited.
The legal entities of Stimuplant currently have 11 directors, including Hardeep Singh, Jaidev Rajnikant Shroff, Vikram Rajnikant Shroff and others.